Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials

por Kim, Jongphil, Schell, Michael J.
Publicado 2019

Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups

por Lee, Ji-Hyun, Schell, Michael J., Roetzheim, Richard
Publicado 2009

Do mammals make all their own inositol hexakisphosphate?

por Letcher, Andrew J., Schell, Michael J., Irvine, Robin F.
Publicado 2008

Transplanted Neural Progenitor Cells from Distinct Sources Migrate Differentially in an Organotypic Model of Brain Injury

por Ngalula, Kapinga P., Cramer, Nathan, Schell, Michael J., Juliano, Sharon L.
Publicado 2015

Techniques to produce and evaluate realistic multivariate synthetic data

por Heine, John, Fowler, Erin E. E., Berglund, Anders, Schell, Michael J., Eschrich, Steven
Publicado 2023

SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer

por Li, Jiannong, Smalley, Inna, Schell, Michael J, Smalley, Keiran S M, Chen, Y Ann
Publicado 2017

A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy

por Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe, Dickinson, Shohreh, Schell, Michael J.
Publicado 2020

Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma

por Mo, Qianxing, Wan, Lixin, Schell, Michael J., Jim, Heather, Tworoger, Shelley S., Peng, Guang
Publicado 2021

Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era

por Kim, Richard, Schell, Michael J., Teer, Jamie K., Greenawalt, Danielle M., Yang, Mingli, Yeatman, Timothy J.
Publicado 2015

The regulation and function of inositol 1,4,5-trisphosphate 3-kinases

por Irvine, Robin F., Lloyd-Burton, Samantha M., Yu, Jowie C.H., Letcher, Andrew J., Schell, Michael J.
Publicado 2006

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors

por Perez, Lia Elena, Fernandez, Hugo, Ayala, Ernesto, Beato, Francisca, Neuger, Anthony, Pidala, Joseph, Schell, Michael J., Anasetti, Claudio
Publicado 2016

PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation

por Davis, Thomas B., Yang, Mingli, Schell, Michael J., Wang, Heiman, Ma, Le, Pledger, W. Jack, Yeatman, Timothy J.
Publicado 2018

Green tea extract for prevention of prostate cancer progression in patients on active surveillance

por Kumar, Nagi B., Dickinson, Shohreh I., Schell, Michael J., Manley, Brandon J., Poch, Michael A., Pow-Sang, Julio
Publicado 2018

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer

por Omolo, Bernard, Yang, Mingli, Lo, Fang Yin, Schell, Michael J., Austin, Sharon, Howard, Kellie, Madan, Anup, Yeatman, Timothy J.
Publicado 2016

Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer

por Kumar, Nagi B., Patel, Roshni, Pow-Sang, Julio, Spiess, Philippe E., Salup, Raoul, Williams, Christopher R., Schell, Michael J.
Publicado 2017

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial

por Chen, Dung-Tsa, Schell, Michael J., Fulp, William J., Pettersson, Fredrik, Kim, Sungjune, Gray, Jhanelle E., Haura, Eric B.
Publicado 2019

Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins

por Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe E., Park, Jong, Salup, Raoul, Williams, Christopher R., Parnes, Howard, Schell, Michael J.
Publicado 2016

Voriconazole Provides Effective Prophylaxis for Invasive Fungal Infection in Patients Receiving Glucocorticoid Therapy for Graft-Versus-Host Disease

por Gergis, Usama, Markey, Kelly, Greene, John, Kharfan-Dabaja, Mohamed, Field, Teresa, Wetzstein, Gene, Schell, Michael J., Huang, Yifan, Anasetti, Claudio, Perkins, Janelle
Publicado 2009

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance

por Creelan, Ben C., Gray, Jhanelle E., Tanvetyanon, Tawee, Chiappori, Alberto A., Yoshida, Takeshi, Schell, Michael J., Antonia, Scott J., Haura, Eric B.
Publicado 2019

APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes

por Thota, Ramya, Yang, Mingli, Pflieger, Lance, Schell, Michael J., Rajan, Malini, Davis, Thomas B., Wang, Heiman, Presson, Angela, Pledger, Warren Jack, Yeatman, Timothy J.
Publicado 2021